Eclanamine (U-48,753) is a drug which was patented as an antidepressant, but was never marketed.[1] It acts by inhibiting the reuptake of serotonin and norepinephrine.[2]

See also

References

  1. ^ Triggle DJ (1997). Dictionary of pharmacological agents. London: Chapman & Hall. ISBN 978-0-412-46630-4.
  2. ^ Rees DC (1992). "Chemical structures and biological activities of non-peptide selective kappa opioid ligands". Progress in Medicinal Chemistry. 29: 109–39 (128). doi:10.1016/s0079-6468(08)70006-7. ISBN 978-0-444-89472-4. PMID 1335584.
Allikas: https://en.wikipedia.org/wiki/Eclanamine
No tags for this post.